Question

How long does stem cell therapy for Liver Cirrhosis last?

Durable reversal of cirrhosis has not been established for a generic cell product. Short follow-up or repeated dosing cannot demonstrate lasting improvement in portal hypertension, liver failure or survival.

Medical review statusPending clinical sign-offLast evidence update: 2026-08-05Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

How stem cells are studied for Liver Cirrhosis

Cirrhosis is advanced liver scarring caused by different diseases and can lead to portal hypertension, infection, encephalopathy, cancer and liver failure. Cell proposals aim to influence inflammation or regeneration, but a laboratory mechanism does not show reversal of established fibrosis or restored liver function. Product source, processing, route and disease cause matter.

Am I a candidate? → · Liver Cirrhosis: full overview → · Liver Cirrhosis cost → · Cost →

Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.

Sources & further reading

Explore all sections · Data & downloads

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Request written information